---
figid: PMC8991738__gr3
figtitle: Recent findings on the cellular and molecular mechanisms of action of novel
  food-derived antihypertensive peptides
organisms:
- Nicotiana tabacum
- Oryza sativa
- Glycine max
- Camellia sinensis
- Allium sativum
- Ginkgo biloba
- Cannabis sativa
- Vigna radiata
- Citrullus lanatus subsp. vulgaris
- Jasminum officinale
- Amaranthus caudatus
- Areca catechu
- Chlorella sorokiniana
- Mucuna pruriens
- Pinus resinosa
- Avena nuda
- Gallus gallus
- Oreochromis niloticus
- Paralichthys olivaceus
- Gadus morhua
- Dipturus batis
- Oncorhynchus gorbuscha
- Bothrops jararaca
- Okamejei kenojei
- Nanorana arnoldi
- Pinctada imbricata
- Ruditapes philippinarum
- Euphausia superba
- Parapenaeus longirostris
- Bacillus subtilis
- Lactiplantibacillus plantarum
- Leuconostoc lactis
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Camelus bactrianus
- Homo sapiens
- NA
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC8991738
filename: gr3.jpg
figlink: /pmc/articles/PMC8991738/figure/f0015/
number: F3
caption: Mechanism of antihypertensive properties of peptides by attenuating insulin
  resistance via IP3K/Akt signaling pathway. AHPs is proposed to increase the gene
  expression and enzyme activity of phosphatidylinositiol-3-phosphate kinase (IP3K)
  through its activator- a membrane bound G-protein coupled subclass receptor. IP3K
  activates protein kinase B (Akt) by phosphorylation of Ser473 in its catalytic site
  while Akt activates endothelial nitric oxide synthase (eNOS) by phosphorylation
  of its catalytic residue (Ser1177 or Ser1179 depending on the specie). Similarly,
  the AHPs blocks L-type Ca2+ channel which increases intracellular concentration
  of Ca2+ that associates with calmodulin (Cd) to form Ca2+-Cd complex which initiates
  contraction by depleting NO availability via inhibition of eNOS. Active eNOS synthesizes
  nitric oxide (NO) from L-arginine, and NO activates soluble guanylyl cyclase to
  convert guanosine triphosphate (GTP) to 5’-cylic guanosine monophosphate (cGMP).
  On binding to its site on protein kinase-G (PK-G), cGMP activates PK-G to phosphorylate
  and activate myosin phosphatase (myosin-P). Activate myosin-P dephosphorylates myosin
  and induce the relaxation of vascular endothelial smooth muscle, hence, reduction
  in blood pressure.
papertitle: Recent findings on the cellular and molecular mechanisms of action of
  novel food-derived antihypertensive peptides.
reftext: Innocent U. Okagu, et al. Food Chem (Oxf). 2022 Jul 30;4:100078.
year: '2022'
doi: 10.1016/j.fochms.2022.100078
journal_title: 'Food Chemistry: Molecular Sciences'
journal_nlm_ta: Food Chem (Oxf)
publisher_name: Elsevier
keywords: Bioactive peptides | Antihypertensive peptides | Hypertension | ACE-inhibitory
  peptides | Nutraceuticals | Functional foods
automl_pathway: 0.9414041
figid_alias: PMC8991738__F3
figtype: Figure
redirect_from: /figures/PMC8991738__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8991738__gr3.html
  '@type': Dataset
  description: Mechanism of antihypertensive properties of peptides by attenuating
    insulin resistance via IP3K/Akt signaling pathway. AHPs is proposed to increase
    the gene expression and enzyme activity of phosphatidylinositiol-3-phosphate kinase
    (IP3K) through its activator- a membrane bound G-protein coupled subclass receptor.
    IP3K activates protein kinase B (Akt) by phosphorylation of Ser473 in its catalytic
    site while Akt activates endothelial nitric oxide synthase (eNOS) by phosphorylation
    of its catalytic residue (Ser1177 or Ser1179 depending on the specie). Similarly,
    the AHPs blocks L-type Ca2+ channel which increases intracellular concentration
    of Ca2+ that associates with calmodulin (Cd) to form Ca2+-Cd complex which initiates
    contraction by depleting NO availability via inhibition of eNOS. Active eNOS synthesizes
    nitric oxide (NO) from L-arginine, and NO activates soluble guanylyl cyclase to
    convert guanosine triphosphate (GTP) to 5’-cylic guanosine monophosphate (cGMP).
    On binding to its site on protein kinase-G (PK-G), cGMP activates PK-G to phosphorylate
    and activate myosin phosphatase (myosin-P). Activate myosin-P dephosphorylates
    myosin and induce the relaxation of vascular endothelial smooth muscle, hence,
    reduction in blood pressure.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ITPKB
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - NOS3
  - ENO4
  - PRKG1
  - MYH14
  - MYO6
  - MYO10
  - MYO16
  - MYO19
  - MYH1
  - MYH10
  - MYH11
  - MYH13
  - MYH15
  - MYH16
  - MYH2
  - MYH3
  - MYH4
  - MYH6
  - MYH7
  - MYH7B
  - MYH8
  - MYH9
  - MYO1A
  - MYO1B
  - MYO1C
  - MYO1D
  - MYO1E
  - MYO1F
  - MYO1G
  - MYO1H
  - MYO3A
  - MYO3B
  - MYO5A
  - MYO5B
  - MYO5C
  - MYO7A
  - MYO7B
  - MYO9A
  - MYO9B
  - MYO15A
  - MYO15B
  - MYO18A
  - MYO18B
  - MYL1
  - MYL3
  - MYL4
  - MYL6
  - MYL6B
  - MYL10
  - MYL12A
  - MYL12B
  - MYL2
  - MYL5
  - MYL7
  - MYL9
  - MYL11
  - CAMK2G
  - Pik3r1
  - Akt1
  - Nos3
  - Camk2a
  - Camk2b
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Pkg21D
  - for
  - sqh
  - Mhc
  - Mlc2
  - CaMKII
---
